These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6604365)

  • 21. Conformational changes in C1q upon binding to IgG oligomers.
    Vandenberg RJ; Easterbrook-Smith SB
    FEBS Lett; 1986 Oct; 207(2):276-9. PubMed ID: 3490402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opsonic and physicochemical characteristics of intravenous immunoglobulin preparations.
    van Furth R; Braat AG; Leijh PC; Gardi A
    Vox Sang; 1987; 53(2):70-5. PubMed ID: 3500539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for arginine residues in the immunoglobulin-binding sites of human Clq.
    Comis A; Easterbrook-Smith SB
    Biochim Biophys Acta; 1985 Sep; 842(1):45-51. PubMed ID: 3876114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nature of IgG complexes in alcoholic liver disease.
    Stoltenberg PH; Soltis RD
    Hepatology; 1984; 4(1):101-6. PubMed ID: 6607202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of immune complex lattice on the C1q solid phase assay as determined with covalently cross-linked immune complexes.
    Wener MH; Mannik M
    Clin Exp Immunol; 1983 Jun; 52(3):543-50. PubMed ID: 6603296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Determination of circulating immune complexes and of their component immunoglobulin classes M, G, and A with a C1q-ELISA].
    Sequeira Peña GA; Herrmann D; Vogt KH; Jäger L
    Allerg Immunol (Leipz); 1991; 37(1):37-45. PubMed ID: 2063729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of various immunoglobulin preparations for intravenous application. II. Complement activation and binding to staphylococcus protein A.
    Römer J; Späth PJ; Skvaril F; Nydegger UE
    Vox Sang; 1982 Feb; 42(2):74-80. PubMed ID: 6461133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of IgG rheumatoid factor (RF) production by antibody-antibody (RF-like) immune complexes: the role of T cells, complement and Fc gamma receptors.
    Nordström E; Möller E; Abedi-Valugerdi M
    J Autoimmun; 1998 Apr; 11(2):131-40. PubMed ID: 9650092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of immunoglobulins and immune complexes to cartilage derived extracts.
    Alomari WR; Archer JR; Brocklehurst R; Currey HL
    Clin Exp Immunol; 1983 Dec; 54(3):716-22. PubMed ID: 6606513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibronectin binding to C1q associated with antigen-antibody complexes in EDTA-treated plasma.
    Sorvillo J; Gigli I; Pearlstein E
    Scand J Immunol; 1986 Feb; 23(2):153-60. PubMed ID: 3081998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [IgG-bound DNA and C1q-binding materials in iupus nephritis].
    Koyama A; Narita M; Lshida H; Inage H; Sano M; Tojo S
    Nihon Jinzo Gakkai Shi; 1982 Mar; 24(3):267-74. PubMed ID: 6981719
    [No Abstract]   [Full Text] [Related]  

  • 32. Quantitative analysis of the interaction between immune complex and C1q complement subcomponent. The role of interdomain interactions in rabbit IgG in binding of C1q to immune precipitates.
    Vonderviszt F; Török J; Lakatos S; Kilár F; Závodszky P
    Biochem J; 1987 Apr; 243(2):449-55. PubMed ID: 3498482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of in vitro behaviour and in vivo efficacy of two 7S-immunoglobulin preparations for intravenous use.
    Stephan W; Dichtelmüller H
    Arzneimittelforschung; 1983; 33(11):1538-40. PubMed ID: 6686449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteins involved in the activation and control of the two pathways of human complement.
    Reid KB
    Biochem Soc Trans; 1983 Jan; 11(1):1-12. PubMed ID: 6298023
    [No Abstract]   [Full Text] [Related]  

  • 35. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.
    Brown EJ; Hosea SW; Hammer CH; Burch CG; Frank MM
    J Clin Invest; 1982 Jan; 69(1):85-98. PubMed ID: 7054244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo degradation of rat C1q induced by intravenous injection of soluble IgG aggregates.
    Veerhuis R; van Es LA; Daha MR
    Immunology; 1985 Apr; 54(4):801-10. PubMed ID: 3872261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trapping antigen-antibody complexes within the human placenta.
    Wood GW; King CR
    Cell Immunol; 1982 May; 69(2):347-62. PubMed ID: 7049408
    [No Abstract]   [Full Text] [Related]  

  • 38. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
    Larsson A; Sjöquist J
    J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.
    Antón LC; Alcolea JM; Sánchez-Corral P; Marqués G; Sánchez A; Vivanco F
    Biochem J; 1989 Feb; 257(3):831-8. PubMed ID: 2784671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for histidine residues in the immunoglobulin-binding site of human Clq.
    Easterbrook-Smith SB
    Biosci Rep; 1983 Feb; 3(2):135-40. PubMed ID: 6221769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.